ANTONELLI, GIORGIA
 Distribuzione geografica
Continente #
NA - Nord America 3.178
EU - Europa 338
AS - Asia 175
SA - Sud America 8
OC - Oceania 1
Totale 3.700
Nazione #
US - Stati Uniti d'America 3.176
CN - Cina 151
IT - Italia 102
SE - Svezia 80
FI - Finlandia 42
DE - Germania 36
GB - Regno Unito 22
UA - Ucraina 11
HK - Hong Kong 10
IN - India 8
IE - Irlanda 7
NL - Olanda 7
RU - Federazione Russa 7
FR - Francia 6
RO - Romania 5
PE - Perù 4
BR - Brasile 3
BE - Belgio 2
BZ - Belize 2
CH - Svizzera 2
JP - Giappone 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
CZ - Repubblica Ceca 1
ES - Italia 1
HR - Croazia 1
IL - Israele 1
LT - Lituania 1
MD - Moldavia 1
PH - Filippine 1
PT - Portogallo 1
UY - Uruguay 1
Totale 3.700
Città #
Fairfield 559
Woodbridge 338
Houston 324
Chandler 307
Ashburn 239
Seattle 222
Cambridge 211
Wilmington 184
Ann Arbor 182
Jacksonville 57
Beijing 53
Princeton 52
San Diego 46
Des Moines 43
Padova 42
Medford 35
Boardman 33
Roxbury 33
Nanjing 26
Helsinki 15
New York 14
Hong Kong 10
Nanchang 10
Milan 9
Redwood City 8
Dublin 7
Cagliari 6
Rome 6
Taizhou 6
Hebei 5
Hefei 5
Jinan 5
San Jose 5
Changsha 4
Lima 4
Norwalk 4
Ogden 4
Shenyang 4
Chicago 3
Dearborn 3
Detroit 3
Frankfurt am Main 3
Freiburg 3
Iasi 3
Kilburn 3
London 3
Orange 3
Phoenix 3
Tianjin 3
Zhengzhou 3
Belize City 2
Borås 2
Bucharest 2
Calvisano 2
Florence 2
Guangzhou 2
Hounslow 2
Jiaxing 2
Los Angeles 2
Mel 2
Naples 2
Palmas 2
Paris 2
Sant'elena 2
Sassuolo 2
Sona 2
Stockholm 2
Tokyo 2
Villorba 2
Amelia 1
Atlanta 1
Augusta 1
Bologna 1
Borgo Ticino 1
Brussels 1
Böblingen 1
Canberra 1
Castelnuovo di Val di Cecina 1
Cebu City 1
Chiswick 1
Chongqing 1
Cormeilles-en-Parisis 1
Council Bluffs 1
Dubai 1
Edinburgh 1
Frankfurt (Oder) 1
Fuzhou 1
Groningen 1
Gunzenhausen 1
Hangzhou 1
Huzhou 1
Indiana 1
Kennewick 1
Kharkiv 1
Kirby 1
Kunming 1
Lisbon 1
Lucknow 1
Madrid 1
Montevideo 1
Totale 3.222
Nome #
An approach for estimating measurement uncertainty in medical laboratories using data from long-term quality control and external quality assessment schemes 139
Cortisol assays and diagnostic laboratory procedures in human biological fluids. 124
First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS 124
Growth hormone isoforms,segments/fragments:Does a link exist with multifunctionality? 119
Performance criteria and quality indicators for the post-analytical phase 118
Erratum to "urinary high performance reverse phase chromatography cortisol and cortisone analyses before and at the end of a race in elite cyclists." 117
Screening tests for cushing's syndrome: Urinary free cortisol role measured by LC-MS/MS 116
Human saliva cortisone and cortisol simultaneous analysis using reverse phase HPLC technique 112
Measurement of free IGF-I saliva levels: perspectives in the detection of GH/IGF axis in athletes. 111
Improved salivary cortisol rhythm with dual-release hydrocortisone 109
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 109
Metyrapone treatment in Cushing’s syndrome: a real-life study 108
What information on measurement uncertainty should be communicated to clinicians, and how? 101
The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing's syndrome: the use of a LC-MS/MS method in routine clinical practice 100
Salivary free insulin-like growth factor-i levels: effects of an acute physical exercise in athletes 100
Urinary high performance reverse phase chromatography cortisol and cortisone analyses before and at the end of a race in elite cyclists 98
Saliva specimen: a new laboratory tool for diagnostic and basic investigation. 98
Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma 94
Natriuretic peptide fragments as possible biochemical markers of hypertension in the elderly. 92
Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination 91
Automated saliva processing for LC-MS/MS: Improving laboratory efficiency in cortisol and cortisone testing 88
Saliva protein pattern, a new laboratory investigation tool for athletes 87
Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results 87
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. 86
Effects of two different types of exercise on GH/IGF axis in athletes. Is the free/total IGF-I ratio a new investigative approach? 85
Salivary cortisol and cortisone by LC-MS/MS: Validation, reference intervals and diagnostic accuracy in Cushing's syndrome 85
Human saliva total protein levels by AV17 pigment based analysis:validation,stability and short variation study 84
Immunosuppressant therapeutic drug monitoring by LC-MS/MS: Workflow optimization through automated processing of whole blood samples 84
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH dependent Cushing's syndrome 84
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 83
N-terminal pro C-type natriuretric peptide relation with prolactin in the elderly 81
Cortisol and cortisone ratio in urine: LC-MS/MS method validation and preliminary clinical application. 77
Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development and validation 73
Urine cortisol and cortisone and water intake in athletes 68
IGF-I/IGFBP system: metabolism outline and physical exercise 68
Mass spectrometry or immunoassay: est modus in rebus 67
Verification of examination procedures in clinical laboratory for imprecision, trueness and diagnostic accuracy according to ISO 15189:2012: a pragmatic approach 64
Androstenedione and 17-α-Hydroxyprogesterone Are Better Indicators of Adrenal Vein Sampling Selectivity Than Cortisol 59
Low-dose short synacthen test with salivary cortisol in patients with suspected central adrenal insufficiency 54
Cardiac biomarkers of acute coronary syndrome: from history to high-sensitive cardiac troponin 48
Molecular endocrinology approach in patho-physiological conditions: new markers and alternative biological matrices 47
Garantire la comparabilità dei risultati nel rispetto dei requisiti di qualità e delle esigenze organizzative: l’esempio di una procedura operativa 34
Comparison of cortisol, androstenedione and metanephrines to assess selectivity and lateralization of adrenal vein sampling in primary aldosteronism 19
Association of autoantibodies targeting endothelin type-A receptors with no-reflow in ST-elevation myocardial infarction 14
Paradoxical GH increase after oral glucose load in subjects with and without acromegaly 11
Heat inactivation of SARS-CoV 2 enabled the measurement of salivary cortisol during COVID-19 pandemic 2
Totale 3.819
Categoria #
all - tutte 12.682
article - articoli 12.216
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019202 0 0 0 0 0 0 0 0 0 0 105 97
2019/2020770 86 27 7 41 93 60 78 88 103 87 65 35
2020/2021690 34 41 15 63 24 77 36 33 110 70 115 72
2021/2022744 22 110 100 45 49 40 39 73 18 11 71 166
2022/2023560 127 74 23 51 82 64 5 39 61 5 21 8
2023/2024261 11 26 50 29 21 25 62 23 7 7 0 0
Totale 3.819